After targeting small interfering RNA to SPTBN1 and SPTBN2, we identified SPTBN1 as a candidate target in ccRCC among Spectrin-family genes (Fig. 1F). The gene discussed is SPTBN2; the disease is nonpapillary renal cell carcinoma.